LEYDEN LABS
Summary
Developer of preventive medicines designed to target respiratory viruses. The company's medicines target commonalities of virus families to protect against many viruses simultaneously as opposed to vaccines that typically protect against a specific virus variant, thereby providing people with the freedom to protect themselves from infection and prevent transmission.
Deals Overview
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
Senior Management
Jaap Goudsmit
Co-Founder and Chief Scientific Officer
Koenraad Wiedhaup
Founder and CEO
Ronald Brus
Co-Founder